ストックスクリーナーアプリを入手
30.42
0.75%
-0.23
アフターアワーズ：
30.45
0.03
+0.10%
Forte Biosciences Inc (FBRX) 最新ニュース
(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
FBRX PE Ratio & Valuation, Is FBRX Overvalued - Intellectia AI
Forte Biosciences (FBRX) Raised to Buy: Key Information You Need - Bitget
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Pullback Watch: Is Forte Biosciences Inc a top pick in the sector2025 Risk Factors & Low Volatility Stock Suggestions - baoquankhu1.vn
Is Forte Biosciences Inc. a top pick in the sectorWeekly Stock Summary & Weekly Watchlist for Hot Stocks - mfd.ru
Will Forte Biosciences Inc. benefit from rate cutsQuarterly Portfolio Report & Stepwise Swing Trade Plans - mfd.ru
Price-Driven Insight from (FBRX) for Rule-Based Strategy - Stock Traders Daily
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Analyst Downgrade: Is Forte Biosciences Inc stock a good dividend stockCEO Change & Growth Focused Entry Reports - baoquankhu1.vn
We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business Growth - Yahoo Finance
Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ - openPR.com
Growth Recap: How much upside does KWESST Micro Systems Inc Equity Warrant havePortfolio Performance Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Why Forte Biosciences Inc. stock is popular among millennialsJuly 2025 Reactions & Daily Profit Maximizing Tips - mfd.ru
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Decrease in Short Interest - MarketBeat
Why Airbnb Inc. stock is favored by top institutionsJuly 2025 Institutional & Reliable Price Breakout Alerts - mfd.ru
Celiac Disease Clinical Trial Pipeline Gains Momentum As 25+ Companies Advance Novel Therapies Toward Market Entry: Delveinsight Teva Pharmaceutical Industries, Barinthus Biotherapeutics, Topas - Menafn.com
Janus Henderson discloses 11.4% Forte Biosciences (FBRX) ownership stake - Stock Titan
Will Forte Biosciences Inc. stock deliver better than expected guidanceQuarterly Earnings Report & Proven Capital Preservation Tips - mfd.ru
Is Forte Biosciences Inc. stock a good choice for value investors2025 Technical Patterns & AI Forecast for Swing Trade Picks - mfd.ru
Can Forte Biosciences Inc. maintain its current growth rateDollar Strength & AI Powered Buy/Sell Recommendations - mfd.ru
Institutional Owners May Ignore Forte Biosciences, Inc.'s (NASDAQ:FBRX) Recent US$87m Market Cap Decline as Longer-term Profits Stay in the Green - 富途牛牛
Does Forte Biosciences Inc. have pricing powerPortfolio Performance Summary & Growth Focused Stock Pick Reports - mfd.ru
Layoff Watch: Is Forte Biosciences Inc being accumulated by smart moneyJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - marketscreener.com
Forte Biosciences chief lines up Guggenheim, TD Cowen, Barclays talks - Stock Titan
Forte Biosciences Insider Ups Holding By 30% During Year - simplywall.st
Aug Outlook: Will BEAM stock recover after earningsWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
(FBRX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Investors Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Dow Update: Will Forte Biosciences Inc announce a stock splitWeekly Trading Summary & Weekly Momentum Picks - baoquankhu1.vn
Short Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Expands By 55.5% - MarketBeat
Federated Hermes Inc. Acquires 563,147 Shares of Forte Biosciences, Inc. $FBRX - MarketBeat
Celiac Disease Pipeline 2025: FDA Updates, Therapy - openPR.com
(FBRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Celiac Disease Clinical Trial Pipeline Gains Momentum: 25+ - openPR.com
Trend Recap: Can META stock outperform in a bear marketTrade Volume Summary & AI Forecast Swing Trade Picks - baoquankhu1.vn
US Market Recap: What is the earnings history of Jupiter Neurosciences Inc2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
CD122’s double whammy makes for intriguing target - BioWorld MedTech
Is Forte Biosciences Inc. stock oversold or undervaluedJuly 2025 Sector Moves & Real-Time Volume Triggers - Bollywood Helpline
Is Forte Biosciences Inc a top pick in the sectorWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
Support Test: How does INVE compare to its peersQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
Layoff Watch: Is ERAS stock undervalued right nowMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Value Recap: Does Forte Biosciences Inc have pricing powerPortfolio Gains Report & Daily Growth Stock Tips - baoquankhu1.vn
Trade Recap: Is Forte Biosciences Inc. stock a hidden gemWeekly Gains Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 267.7% in December - MarketBeat
Delaware court rules in D&O dispute - businessinsurance.com
Delaware court expands D&O insurer liability through meaningful linkage ruling - Insurance Business
A activityJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - ulpravda.ru
Will Forte Biosciences Inc. stock outperform international peersLayoff News & High Return Stock Watch Alerts - Улправда
Biopharma Co. Secures D&O Coverage For Shareholder Suit - Law360
Why Forte Biosciences Inc. stock is rated strong buyWeekly Investment Summary & Expert Curated Trade Ideas - Улправда
Will Forte Biosciences Inc. stock reach all time highs in 2025CPI Data & Expert Curated Trade Setups - Улправда
How supply shortages influence HCI stockJuly 2025 Review & Community Driven Trade Alerts - Улправда
What margin trends mean for VNET Group Inc. Depositary Receipt stockTrade Risk Report & Long-Term Safe Investment Ideas - Улправда
5.71%
0.02%
大文字化:
|
ボリューム (24 時間):